Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pelvic Cancer: early-phase trial registry
1 of 7 indexed Pelvic Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 1 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Pelvic Cancer: 7 US clinical trials tracked, 1 recruiting.
Pelvic Cancer is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Varian, a Siemens Healthineers Company, running 2 of these trials.
Enrollment posture brief
Registry condition pelvic-cancer
OPEN 1 | RECR 14% | LATE 0 | EARLY 1 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adverse Drug Events (14% recruiting · 7 trials)
Pelvic Cancer lists 1 open slots (14% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pelvic Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pelvic Cancer is recruiting below its size-band peers.
1 of 7 indexed trials (14.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Pelvic Cancer research.
Varian, a Siemens Healthineers Company accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Pelvic Cancer trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 7 trials that report a genuine target (sentinel values excluded). 6 of those (85.7%) plan for fewer than 100 participants.
-
Pelvic Cancer research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
M.D. Anderson Cancer Center
NCT00493688
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
NCT06187103
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
Varian, a Siemens Healthineers Company
NCT05975619
Ablative Stereotactic MR-Guided Adaptive Reirradiation
Baptist Health South Florida
NCT06397573
Pediatric Oncology Recovery Trial After Surgery
University of Colorado, Denver
NCT04344899
Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
NCT00437372
Prehabilitation for Pelvic Cancer: Changes in Setup Variability
University of Massachusetts, Worcester
NCT03242538
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pelvic Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pelvic Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pelvic Cancer page
7 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Pelvic Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Varian, a Siemens Healthineers Company sponsors the most Pelvic Cancer trials on record, review their full trial history before evaluating a specific study. See Varian, a Siemens Healthineers Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pelvic Cancer condition card totals 7 registered trials; most-linked intervention Pelvic Exercise; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.